Testing for Antibodies Against Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in the Diagnosis of Patients With Suspected Autoimmune Myelopathy
Autoimmune myelopathies are immune-mediated disorders of the spinal cord that can cause significant neurologic disability. Discoveries of antibodies targeting aquaporin-4 (AQP4-IgG) and myelin oligodendrocyte glycoprotein (MOG-IgG) have facilitated the diagnosis of autoimmune myelopathies that were...
Main Authors: | Samir Alkabie, Adrian Budhram |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2022.912050/full |
Similar Items
-
Meningo-cortical manifestations of myelin oligodendrocyte glycoprotein antibody-associated disease: Review of a novel clinico-radiographic spectrum
by: Adrian Budhram, et al.
Published: (2022-10-01) -
Myelin oligodendrocyte glycoprotein antibody titers by fixed cell-based assay: positive predictive value and impact of sample collection timing
by: Adrian Budhram, et al.
Published: (2024-03-01) -
Transverse myelitis in myelin oligodendrocyte glycoprotein antibody-associated disease
by: Gina Perez-Giraldo, et al.
Published: (2023-07-01) -
Clinical and Imaging Features of Patients With Encephalitic Symptoms and Myelin Oligodendrocyte Glycoprotein Antibodies
by: Jingsi Wang, et al.
Published: (2021-10-01) -
Oligodendrocyte myelin glycoprotein as a novel target for pathogenic autoimmunity in the CNS
by: Ramona Gerhards, et al.
Published: (2020-11-01)